Tozinameran/famtozinameran - Pfizer
Alternative Names: Comirnaty Original/Omicron BA.4-5; Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccineLatest Information Update: 08 May 2023
Price :
$50 *
At a glance
- Originator BioNTech
- Developer BioNTech; Pfizer
- Class COVID-19 vaccines; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered COVID 2019 infections
Most Recent Events
- 18 Apr 2023 Registered for COVID-2019 infections (In adolescents, In adults, In children, In infants, In the elderly, Prevention) in USA (IM)
- 24 Feb 2023 Clinical trials in COVID-2019 infections (Prevention) in USA (IM) before February 2023
- 24 Feb 2023 Preregistration for COVID-2019 infections (In adolescents, In adults, In the elderly, Prevention) in USA (IM)